SYHX-1903

N/A

Report date: 2023/05/30 20:00:25
NME

Base Information

Drug NameSYHX-1903
Drug Alias NameSYHX-1903
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsHematologic NeoplasmsMultiple MyelomaLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd
Inactive CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Active IndicationsMultiple MyelomaLymphomaLeukemia, Myeloid, Acute
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A